Oral drug to treat Black Fungus ready for technology transfer, says IIT-Hyd researchers


PTI, May 30, 2021, 10:11 AM IST

Hyderabad: Researchers at the Indian Institute of Technology, Hyderabad, have developed an oral solution to treat Black Fungus (Mucormycosis) and other fungus and are ready to transfer the technology to take it forward, the premier institute said.

A 60-mg tablet, which can be priced at about Rs 200, is patient-friendly as its slow and sustained release in the body reduces nephrotoxicity (adverse impact of medicines and chemicals on the kidney), IIT said in a release on Saturday.

Professor Saptarshi Majumdar and Dr Chandra Shekhar Sharma from the Department of Chemical Engineering have made a proven study about oral nanofibrous AMB to be effective for Kala Azar (visceral leishmaniasis).

”With the two years of advancement of examination, the researchers are now confident that the technology can be transferred to suitable pharma partners for large-scale production. At present, the Kala-Azar treatment is being used as a treatment for Black and other Fungus in the country and its availability and affordability make it need to allow emergency and immediate trial of this oral drug,” IIT-H said.

The technology developed is made free from intellectual property rights so that it can be mass-produced and is affordable and available to the public at large, Dr Chandra Shekhar Sharma said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

ED turned down plea for exemption from appearance: Cong leader Shivakumar

Threats to Mukesh Ambani’s family: One held from Bihar

Will respond to Rahul Gandhi’s letter on injured elephant on humanitarian grounds: CM

Ind vs SA: Start of first ODI delayed due to rain

Shivamogga: Earthquake tremors felt in Shiralakoppa; screenshot goes viral

Sushmita Sen to play transgender activist Gauri Sawant in new series ‘Taali’, drops first look

Sonia Gandhi joins Bharat Jodo Yatra in Karnataka


Related Articles More

Compound in some mouthwashes may suppress COVID-19, study finds

BA.2 variant in around 90% Covid samples genome-sequenced in Delhi in July-Aug

WHO alert for four Indian syrups as 66 children die in Gambia

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

Labcorp Drug Development selects Dr. Deepa Desai as Country head for India

MUST WATCH

Uchila Dasara 2022 : Final Preparation for Precession

Bharath Judo : Rahul Gandhi Speach in Rain

Day 8 | Mahagauri

Sarapady Devadas Special Video.

Day 7 | Goddess Kalratri


Latest Additions

ED turned down plea for exemption from appearance: Cong leader Shivakumar

Threats to Mukesh Ambani’s family: One held from Bihar

Palakkad bus accident: Kerala HC seeks report from police, MVD

Congress’ Bharat Jodo Yatra will have no impact: Bommai

Compound in some mouthwashes may suppress COVID-19, study finds

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.